Publication
Article
Pharmacy Times
Insomnia is a common problem for children and adolescentswith attention-deficit/hyperactivity disorder (ADHD). Research hasshown that daytime drowsiness because of insufficient sleep canlead to learning and attention problems.
A new clinical trial, posted November 2005 on the www.clinicaltrials.gov Web site, is recruiting children and adolescents withADHD-related insomnia. The purpose of the study is to examinethe effects of a nonstimulating drug, atomoxetine—which is indicatedfor the treatment of ADHD—on ADHD-related insomnia. Amajority of drugs indicated for the treatment of ADHD symptomsin children and adults are stimulating and can aggravate sleepproblems. There is evidence that the trial's drug may improvesleep in children with ADHD.